01
Why immune menus include it
Thymic peptide research is decades old. U.S. compounding eligibility is a different question.
- ·Immune-modulator interest
- ·Not orderable at RE GEN
- ·Not a COVID protocol we sell
RE GEN RX · peptides / Thymosin Alpha-1
No lawful pathway
Thymosin Alpha-1
An immune-modulator peptide — not nominated, no lawful §503A pathway.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · Immune modulator
What is Thymosin Alpha-1?
The molecule, in plain language.
Thymosin alpha-1 (TA-1, thymalfasin) has a real pharmaceutical history in some countries as an immune modulator. In the U.S. 503A compounding lane RE GEN uses, it is not nominated into a pathway we can use. We will not compound it.
How people usually take it. Not orderable.
What people are actually trying to solve.
Interest is not a result. We keep the research language and skip the miracle.
02
Not TB-500
Thymosin alpha-1 and thymosin beta-4 / TB-500 are different molecules with different legal files. Both are no for us today, for different reasons.
- ·TA-1: not nominated
- ·TB-500: PCAC recommended, not listed
- ·Neither is orderable
03
Illness still needs real care
Do not wait on a peptide landing page if you have an infection or are immunocompromised without a physician.
- ·Appropriate medical care first
- ·We will not gray-market TA-1
- ·Start a visit for carried tools later
What the evidence actually is — and what it isn’t.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Animal research
Thymosin alpha-1 has preclinical immune-modulation literature.
- ·Not 503A eligibility here
- ·Not orderable
- ·Not a vaccine replacement
Human research
Thymalfasin is used in some countries as a drug. That does not create a 503A basis for RE GEN today.
- ·Not orderable
- ·No immune-score promise
- ·Do not buy research TA-1
Legal basis at RE GEN · July 2026
We will not compound this today.
Not nominated / no lawful §503A pathway at this time. We will not compound thymosin alpha-1.
We will not compound this. Ask us what is carried instead.
Common questions
Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
What is thymosin alpha-1?
An immune-modulator peptide (thymalfasin). Not nominated into a lawful 503A pathway RE GEN can use. Not orderable.
Is thymosin alpha-1 FDA-approved?
thymosin alpha-1 is not FDA-approved, and RE GEN does not have a lawful §503A pathway to request it as a compounded medication today. A committee vote is not approval.
Can I get thymosin alpha-1 at RE GEN in Oswego?
You can start a visit to talk about your goal. We will not compound thymosin alpha-1 today. We will show you what is carried instead — and we will say no rather than gray-market a vial.
Is it the same as TB-500?
No. Different thymosin. Different legal status. Neither is orderable here today.
Do you promise results?
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.
Related on this menu
Illinois practice · licensed 503A compounding
We will tell you no — and show you what is carried instead.
Hello Gorgeous PC · 74 W. Washington St, Oswego, IL
RE GEN desk 630-636-6193
Start a visit, a licensed Illinois clinician reviews, then you pay the invoice. If they don't prescribe, we refund.